GW Pharma CEO on recent cannabis-derived drug

GW Pharma CEO on recent cannabis-derived drug

GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says referring to the capacity forward for cannabis-derived treatment.

Tilray CEO says the Canadian cannabis replace wants a frontrunner

Tilray CEO says the Canadian cannabis replace wants a frontrunner

Irwin Simon, Tilray CEO, joins ‘Closing Bell: Beyond frequent time’ to discuss the company’s M&A technique, earnings and Canada’s cannabis replace and regulation. For get entry to to live and…

Inexperienced Thumb CEO on cannabis growth: Particular person search data from is excessive

Inexperienced Thumb CEO on cannabis growth: Particular person search data from is excessive

CNBC’s “Mumble on the Avenue” crew discusses pot stock ETFs and sector growth with Inexperienced Thumb Industries CEO Ben Kovler. For catch admission to to are living and odd video…

Scotts Miracle-Gro CEO on legalizing cannabis

Scotts Miracle-Gro CEO on legalizing cannabis

James Hagedorn, Scotts Miracle-Gro chairman and CEO, joins “Recount on the Avenue” to discus the housing market, legalization of cannabis and more.

Tilray CEO on shares being down, oversupply, U.S. cannabis regulation and Canada expansion plans

Tilray CEO on shares being down, oversupply, U.S. cannabis regulation and Canada expansion plans

Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to boom referring to the firm’s shares being down all over the final 12 months and what headwinds the firm goes through.

GrowGeneration CEO seeks ‘extra sturdy’ cannabis licensing

GrowGeneration CEO seeks ‘extra sturdy’ cannabis licensing

GrowGeneration CEO and co-founder Darren Lampert joined CNBC’s Jim Cramer on Tuesday’s episode of “Wrathful Money,” explaining why he modified into as soon as optimistic on cannabis licensing all the…

Green Thumb CEO on cannabis explain: Consumer question is high

Green Thumb CEO on cannabis explain: Consumer question is high

CNBC’s “Verbalize on the Road” group discusses pot stock ETFs and sector explain with Green Thumb Industries CEO Ben Kovler.

Hydrofarm CEO on how the cannabis alternate will evolve

Hydrofarm CEO on how the cannabis alternate will evolve

Hydrofarm CEO Invoice Toler explained why the agriculture equipment maker expects most marijuana grow operations will happen indoors as a change of begin air. Subscribe to CNBC PRO for ranking…

Parallel CEO of cannabis company Parallel on going public via SPAC

Parallel CEO of cannabis company Parallel on going public via SPAC

Beau Wrigley is Parallel chairman and CEO and discusses taking his cannabis business public through a SPAC merger. For access to live and exclusive video from CNBC subscribe to CNBC…

Green Thumb CEO on cannabis legalization and new products

Green Thumb CEO on cannabis legalization and new products

Benjamin Kovler, Green Thumb Industries CEO, joins ‘Power Lunch’ to discuss why the company’s shares are down despite the announcement that it is entering the California market. For access to…